Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
Clinical trial NCT01000506 · COMPLETED
Trial details
- NCT number
- NCT01000506
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2012-03-23
- Enrollment
- 621
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.